RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation

J. H. Kim, J. W. Jang, Y. S. Lee, J. W. Lee, X. Z. Chi, Y. H. Li, M. K. Kim, D. M. Kim, B. S. Choi, J. Kim, H. M. Kim, Andre J van Wijnen, Ily Park, S. C. Bae

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Transcription factors of the RUNX family (RUNXs), which play pivotal roles in normal development and neoplasia, are regulated by various post-translational modifications. To understand the molecular mechanisms underlying the regulation of RUNXs, we performed a large-scale functional genetic screen of a fly mutant library. The screen identified dPias (the fly ortholog of mammalian PIASs), an E3 ligase for the SUMO (small ubiquitin-like modifier) modification, as a novel genetic modifier of lz (the fly ortholog of mammalian RUNX3). Molecular biological analysis revealed that lz/RUNXs are sumoylated by dPias/PIAS1 at an evolutionarily conserved lysine residue (K372 of lz, K144 of RUNX1, K181 of RUNX2 and K148 of RUNX3). PIAS1-mediated sumoylation inhibited RUNX3 transactivation activity, and this modification was promoted by the AKT1 kinase. Importantly, PIAS1 failed to sumoylate some RUNX1 mutants associated with breast cancer. In nude mice, tumorigenicity was promoted by RUNX3 bearing a mutation in the sumoylation site, but suppressed by wild-type RUNX3. Our results suggest that RUNXs are sumoylated by PIAS1, and that this modification could play a critical role in the regulation of the tumor-suppressive activity of these proteins.

Original languageEnglish (US)
Article numbere101
JournalOncogenesis
Volume3
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Sumoylation
Diptera
Ubiquitin-Protein Ligases
Post Translational Protein Processing
Nude Mice
Transcriptional Activation
Lysine
Neoplasms
Transcription Factors
Phosphotransferases
Breast Neoplasms
Mutation
Proteins

Keywords

  • AKT1
  • PIAS1
  • RUNX3
  • sumoylation
  • tumor suppressor

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Kim, J. H., Jang, J. W., Lee, Y. S., Lee, J. W., Chi, X. Z., Li, Y. H., ... Bae, S. C. (2014). RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation. Oncogenesis, 3(4), [e101]. https://doi.org/10.1038/oncsis.2014.15

RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation. / Kim, J. H.; Jang, J. W.; Lee, Y. S.; Lee, J. W.; Chi, X. Z.; Li, Y. H.; Kim, M. K.; Kim, D. M.; Choi, B. S.; Kim, J.; Kim, H. M.; van Wijnen, Andre J; Park, Ily; Bae, S. C.

In: Oncogenesis, Vol. 3, No. 4, e101, 01.01.2014.

Research output: Contribution to journalArticle

Kim, JH, Jang, JW, Lee, YS, Lee, JW, Chi, XZ, Li, YH, Kim, MK, Kim, DM, Choi, BS, Kim, J, Kim, HM, van Wijnen, AJ, Park, I & Bae, SC 2014, 'RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation', Oncogenesis, vol. 3, no. 4, e101. https://doi.org/10.1038/oncsis.2014.15
Kim, J. H. ; Jang, J. W. ; Lee, Y. S. ; Lee, J. W. ; Chi, X. Z. ; Li, Y. H. ; Kim, M. K. ; Kim, D. M. ; Choi, B. S. ; Kim, J. ; Kim, H. M. ; van Wijnen, Andre J ; Park, Ily ; Bae, S. C. / RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation. In: Oncogenesis. 2014 ; Vol. 3, No. 4.
@article{f39d5f87d0c94bfd9bff630c58fbc3d3,
title = "RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation",
abstract = "Transcription factors of the RUNX family (RUNXs), which play pivotal roles in normal development and neoplasia, are regulated by various post-translational modifications. To understand the molecular mechanisms underlying the regulation of RUNXs, we performed a large-scale functional genetic screen of a fly mutant library. The screen identified dPias (the fly ortholog of mammalian PIASs), an E3 ligase for the SUMO (small ubiquitin-like modifier) modification, as a novel genetic modifier of lz (the fly ortholog of mammalian RUNX3). Molecular biological analysis revealed that lz/RUNXs are sumoylated by dPias/PIAS1 at an evolutionarily conserved lysine residue (K372 of lz, K144 of RUNX1, K181 of RUNX2 and K148 of RUNX3). PIAS1-mediated sumoylation inhibited RUNX3 transactivation activity, and this modification was promoted by the AKT1 kinase. Importantly, PIAS1 failed to sumoylate some RUNX1 mutants associated with breast cancer. In nude mice, tumorigenicity was promoted by RUNX3 bearing a mutation in the sumoylation site, but suppressed by wild-type RUNX3. Our results suggest that RUNXs are sumoylated by PIAS1, and that this modification could play a critical role in the regulation of the tumor-suppressive activity of these proteins.",
keywords = "AKT1, PIAS1, RUNX3, sumoylation, tumor suppressor",
author = "Kim, {J. H.} and Jang, {J. W.} and Lee, {Y. S.} and Lee, {J. W.} and Chi, {X. Z.} and Li, {Y. H.} and Kim, {M. K.} and Kim, {D. M.} and Choi, {B. S.} and J. Kim and Kim, {H. M.} and {van Wijnen}, {Andre J} and Ily Park and Bae, {S. C.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1038/oncsis.2014.15",
language = "English (US)",
volume = "3",
journal = "Oncogenesis",
issn = "2157-9024",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation

AU - Kim, J. H.

AU - Jang, J. W.

AU - Lee, Y. S.

AU - Lee, J. W.

AU - Chi, X. Z.

AU - Li, Y. H.

AU - Kim, M. K.

AU - Kim, D. M.

AU - Choi, B. S.

AU - Kim, J.

AU - Kim, H. M.

AU - van Wijnen, Andre J

AU - Park, Ily

AU - Bae, S. C.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Transcription factors of the RUNX family (RUNXs), which play pivotal roles in normal development and neoplasia, are regulated by various post-translational modifications. To understand the molecular mechanisms underlying the regulation of RUNXs, we performed a large-scale functional genetic screen of a fly mutant library. The screen identified dPias (the fly ortholog of mammalian PIASs), an E3 ligase for the SUMO (small ubiquitin-like modifier) modification, as a novel genetic modifier of lz (the fly ortholog of mammalian RUNX3). Molecular biological analysis revealed that lz/RUNXs are sumoylated by dPias/PIAS1 at an evolutionarily conserved lysine residue (K372 of lz, K144 of RUNX1, K181 of RUNX2 and K148 of RUNX3). PIAS1-mediated sumoylation inhibited RUNX3 transactivation activity, and this modification was promoted by the AKT1 kinase. Importantly, PIAS1 failed to sumoylate some RUNX1 mutants associated with breast cancer. In nude mice, tumorigenicity was promoted by RUNX3 bearing a mutation in the sumoylation site, but suppressed by wild-type RUNX3. Our results suggest that RUNXs are sumoylated by PIAS1, and that this modification could play a critical role in the regulation of the tumor-suppressive activity of these proteins.

AB - Transcription factors of the RUNX family (RUNXs), which play pivotal roles in normal development and neoplasia, are regulated by various post-translational modifications. To understand the molecular mechanisms underlying the regulation of RUNXs, we performed a large-scale functional genetic screen of a fly mutant library. The screen identified dPias (the fly ortholog of mammalian PIASs), an E3 ligase for the SUMO (small ubiquitin-like modifier) modification, as a novel genetic modifier of lz (the fly ortholog of mammalian RUNX3). Molecular biological analysis revealed that lz/RUNXs are sumoylated by dPias/PIAS1 at an evolutionarily conserved lysine residue (K372 of lz, K144 of RUNX1, K181 of RUNX2 and K148 of RUNX3). PIAS1-mediated sumoylation inhibited RUNX3 transactivation activity, and this modification was promoted by the AKT1 kinase. Importantly, PIAS1 failed to sumoylate some RUNX1 mutants associated with breast cancer. In nude mice, tumorigenicity was promoted by RUNX3 bearing a mutation in the sumoylation site, but suppressed by wild-type RUNX3. Our results suggest that RUNXs are sumoylated by PIAS1, and that this modification could play a critical role in the regulation of the tumor-suppressive activity of these proteins.

KW - AKT1

KW - PIAS1

KW - RUNX3

KW - sumoylation

KW - tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=84920676825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920676825&partnerID=8YFLogxK

U2 - 10.1038/oncsis.2014.15

DO - 10.1038/oncsis.2014.15

M3 - Article

VL - 3

JO - Oncogenesis

JF - Oncogenesis

SN - 2157-9024

IS - 4

M1 - e101

ER -